Wespac Advisors So Cal, LLC Acadia Pharmaceuticals Inc Transaction History

Wespac Advisors So Cal, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$23.32 - $28.12 $4,664 - $5,624	-200 Closed	0 $0
Q3 2018 Oct 22, 2018	BUY	$13.03 - $21.81 $2,606 - $4,362	200 New	200 $4,000
Q2 2018 Jul 13, 2018	SELL	$15.07 - $22.34 $3,014 - $4,468	-200 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$26.84 - $39.14 $26,840 - $39,140	-1,000 Reduced 83.33%	200 $6,000
Q2 2017 Aug 11, 2017	BUY	N/A	1,200	1,200 $33,000

281

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.71B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.